Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vertex Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-10 of 10
» View wsbtradio.com items only
    May 8, 2013 |Story| Reuters

  1. Many in U.S. don't get proper testing for hepatitis C- CDC

    Reuters
    By Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...

    Tags: Disease Prevention, Hepatitis C , Viral Diseases and Infections, Diseases and Illnesses, Drugs and Medicines

    2. May 2, 2013 |Story| South Florida Sun-Sentinel

  2. International consortium releases hepatitis C data

    Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...

    Tags: Bristol Myers Squibb Company, Trials, Cirrhosis, Merck & Company Incorporated, Education

    3. May 1, 2013 |Story| Reuters

  3. U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy

    Reuters
    May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...

    Tags: Environmental Issues, Kona Grill Incorporated, Spirit Airlines, Aetna Inc., AGCO Corp.

    4. Apr 30, 2013 |Story| Reuters

  4. Vertex posts quarterly loss as hepatitis C drug sales fall

    Reuters
    April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...

    Tags: Hepatitis C , Biotechnology Industry, Science and Technology, Biotechnology, Chemical Industry

    5. Apr 28, 2013 |Story| Hartford Courant

  5. READER SUBMITTED: American Liver Foundation's Raises $242,000 At Twelfth Annual Flavors Of Connecticut

    Statewide
    The American Liver Foundation (ALF), a non-profit organization focused on promoting liver health and disease prevention held its annual fundraising event, Flavors of Connecticut presented by Hartford Hospital. The event took place on April 9 at the Aqua...

    Tags: Bars and Clubs, Disease Prevention, Restaurants, Diseases and Illnesses, Auction Service

    6. Aug 27, 2012 |Story| WDBJ7

  6. OUR HEALTH: New Hepatitis C Treatment Clinic Brings Specialized Treatment to Local Patients

    Anewly formed infectious disease clinic in Lynchburg, VA is bringing expert medical care to those in the area with hepatitis C.
    Anewly formed infectious disease clinic in Lynchburg, VA is bringing expert medical care to those in the area with hepatitis C. An estimated 3.2 million people in the United States have a chronic hepatitis C viral infection. Most of them don’t even...

    Tags: Disease Prevention, Recreational Substance Use, Death, General Practitioners, HIV

    7. May 18, 2012 |Story| AP Broadcast

  7. CDC to baby boomers: Get tested for hepatitis C

    ATLANTA (AP) — For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for...

    Tags: Disease Prevention, Hepatitis C , Viral Diseases and Infections, General Practitioners, Diseases and Illnesses

    8. Feb 21, 2012 |Story| Petoskey News

  8. Hepatitis C deaths up, baby boomers most at risk

    WASHINGTON (AP)— Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk.
    WASHINGTON (AP)— Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk. Federal health officials are considering whether anyone born between 1945 and 1965...

    Tags: Disease Prevention, Demographics, Human Body, Cirrhosis, Merck & Company Incorporated

    9. Nov 2, 2011 |Story| Los Angeles Times

  9. Cystic fibrosis drug ivacaftor offers patients new hope

    All her life, Lindsay Shipp knew that she was dying. As a baby, she would cry after eating, and salt collected on her forehead. The diagnosis was cystic fibrosis, an incurable genetic disease that, at the time, meant a life expectancy of 18 years.
    All her life, Lindsay Shipp knew that she was dying. As a baby, she would cry after eating, and salt collected on her forehead. The diagnosis was cystic fibrosis, an incurable genetic disease that, at the time, meant a life expectancy of 18 years. The...

    Tags: Cambridge (Middlesex, Massachusetts), Mamma Mia! (musical), Human Body, Diseases and Illnesses, Genes and Chromosomes

    10. May 23, 2011 |Story| Reuters

  10. Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
    Reuters
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...

    Tags: Liver, Human Body, Diseases and Illnesses, Cirrhosis, Drugs and Medicines

Original site for Vertex Pharmaceuticals Incorporated topic gallery.